之江生物: 之江生物：浙江天册律师事务所关于上海之江生物科技股份有限公司2024年年度股东大会的法律意见书

Group 1 - The legal opinion letter is issued by Zhejiang Tiance Law Firm regarding the annual general meeting of Shanghai Zhijiang Biotechnology Co., Ltd. [1][2] - The meeting is scheduled for May 15, 2025, with both on-site and online voting options available [3][4] - The total number of shares held by shareholders attending the meeting is 71,689,004, representing approximately 37.31% of the company's total share capital [6] Group 2 - The voting results indicate that the proposals were approved with a majority, with 73,305,820 shares in favor, 518,244 against, and 208,813 abstentions, resulting in a 99.02% approval rate [7][8] - The voting procedures followed legal and regulatory requirements, ensuring the legitimacy of the meeting and the voting process [9][10] - The conclusion states that the meeting's convening, participant qualifications, and voting procedures comply with relevant laws and regulations, confirming the validity of the voting results [10]